From Identification to Insight: Making Full Use of the Diagnostic Potential of MS/MS Proteotyping in Clinical Microbiology Using Efficient Bioinformatics

Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and functional insight. In this context, mass spectrometry (MS)-based proteomics is rapidly emerging as a transformative approach in clinical microbiology...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of proteome research Jg. 24; H. 11; S. 5336
Hauptverfasser: Muth, Thilo, Karlsson, Roger, Yu, Yi-Kuo, Alves, Gelio
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 07.11.2025
Schlagworte:
ISSN:1535-3907, 1535-3907
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and functional insight. In this context, mass spectrometry (MS)-based proteomics is rapidly emerging as a transformative approach in clinical microbiology, offering comprehensive characterization of microorganisms and direct identification of protein biomarkers relevant to infectious disease diagnostics. While MS1-based approaches such as MALDI-TOF Biotyper have revolutionized species-level microbial identification through rapid and cost-effective workflows, they remain fundamentally limited in resolving strain-level differences and in detecting antimicrobial resistance (AMR) determinants. In contrast, so-called proteotyping enables the identification of organisms and resistance-associated proteins based on peptide sequence information obtained by tandem mass spectrometry (MS/MS), most commonly using shotgun proteomics. However, the clinical utility of proteotyping depends on the availability of efficient and accurate bioinformatics tools capable of handling large databases, disambiguating shared peptide sequences, and providing taxonomic and functional assignments with clinical relevance. This perspective highlights the diagnostic potential of MS/MS proteotyping and argues that advances in bioinformatics pipelines are needed for moving from microbial identification to actionable clinical insight.
AbstractList Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and functional insight. In this context, mass spectrometry (MS)-based proteomics is rapidly emerging as a transformative approach in clinical microbiology, offering comprehensive characterization of microorganisms and direct identification of protein biomarkers relevant to infectious disease diagnostics. While MS1-based approaches such as MALDI-TOF Biotyper have revolutionized species-level microbial identification through rapid and cost-effective workflows, they remain fundamentally limited in resolving strain-level differences and in detecting antimicrobial resistance (AMR) determinants. In contrast, so-called proteotyping enables the identification of organisms and resistance-associated proteins based on peptide sequence information obtained by tandem mass spectrometry (MS/MS), most commonly using shotgun proteomics. However, the clinical utility of proteotyping depends on the availability of efficient and accurate bioinformatics tools capable of handling large databases, disambiguating shared peptide sequences, and providing taxonomic and functional assignments with clinical relevance. This perspective highlights the diagnostic potential of MS/MS proteotyping and argues that advances in bioinformatics pipelines are needed for moving from microbial identification to actionable clinical insight.Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and functional insight. In this context, mass spectrometry (MS)-based proteomics is rapidly emerging as a transformative approach in clinical microbiology, offering comprehensive characterization of microorganisms and direct identification of protein biomarkers relevant to infectious disease diagnostics. While MS1-based approaches such as MALDI-TOF Biotyper have revolutionized species-level microbial identification through rapid and cost-effective workflows, they remain fundamentally limited in resolving strain-level differences and in detecting antimicrobial resistance (AMR) determinants. In contrast, so-called proteotyping enables the identification of organisms and resistance-associated proteins based on peptide sequence information obtained by tandem mass spectrometry (MS/MS), most commonly using shotgun proteomics. However, the clinical utility of proteotyping depends on the availability of efficient and accurate bioinformatics tools capable of handling large databases, disambiguating shared peptide sequences, and providing taxonomic and functional assignments with clinical relevance. This perspective highlights the diagnostic potential of MS/MS proteotyping and argues that advances in bioinformatics pipelines are needed for moving from microbial identification to actionable clinical insight.
Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and functional insight. In this context, mass spectrometry (MS)-based proteomics is rapidly emerging as a transformative approach in clinical microbiology, offering comprehensive characterization of microorganisms and direct identification of protein biomarkers relevant to infectious disease diagnostics. While MS1-based approaches such as MALDI-TOF Biotyper have revolutionized species-level microbial identification through rapid and cost-effective workflows, they remain fundamentally limited in resolving strain-level differences and in detecting antimicrobial resistance (AMR) determinants. In contrast, so-called proteotyping enables the identification of organisms and resistance-associated proteins based on peptide sequence information obtained by tandem mass spectrometry (MS/MS), most commonly using shotgun proteomics. However, the clinical utility of proteotyping depends on the availability of efficient and accurate bioinformatics tools capable of handling large databases, disambiguating shared peptide sequences, and providing taxonomic and functional assignments with clinical relevance. This perspective highlights the diagnostic potential of MS/MS proteotyping and argues that advances in bioinformatics pipelines are needed for moving from microbial identification to actionable clinical insight.
Author Alves, Gelio
Muth, Thilo
Karlsson, Roger
Yu, Yi-Kuo
Author_xml – sequence: 1
  givenname: Thilo
  orcidid: 0000-0001-8304-2684
  surname: Muth
  fullname: Muth, Thilo
  organization: Data Competence Center MF 2, Robert Koch Institute, Berlin 13353, Germany
– sequence: 2
  givenname: Roger
  surname: Karlsson
  fullname: Karlsson, Roger
  organization: Department of Clinical Microbiology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg 41345, Sweden
– sequence: 3
  givenname: Yi-Kuo
  orcidid: 0000-0002-6213-7665
  surname: Yu
  fullname: Yu, Yi-Kuo
  organization: Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894, United States
– sequence: 4
  givenname: Gelio
  orcidid: 0000-0002-1595-1445
  surname: Alves
  fullname: Alves, Gelio
  organization: Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/41159248$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1OAjEUhRuDkR99BE2Xbgb6M52ZulMEJYFIgqxJ6XSg2GlxWhY8im9rUUxc3Zvcc757crqgZZ1VANxi1MeI4IGQvr_bNy4oV6s-kwjllF6ADmaUJZSjvPVvb4Ou9zuEMMsRvQLtFGPGSVp0wNe4cTWclMoGXWkpgnYWBgcn1uvNNjzAmfjQdgPHB2Pg0ivoKhi2Cj5rsbHOBy3hPGaIbmFOt9liMFvA-U-ucNyfrNrCodE2wg2cadm4tXbGbY4RdzqPqvhXRwJ80k7byjV1TCH9NbishPHq5jx7YDkevQ9fk-nby2T4OE0EpTwkJJM8S_NMZUVREsJphhihgla8pCXjuJRYEbYuMKF8XXFZFExU5amAvMhRSkgP3P9yY5mfB-XDqtZeKmOEVe7gV5RkWcoKltIovTtLD-talat9o2vRHFd_dZJvZsN9LA
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/acs.jproteome.5c00733
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Chemistry
EISSN 1535-3907
ExternalDocumentID 41159248
Genre Journal Article
Review
GroupedDBID ---
4.4
53G
55A
5GY
5VS
7~N
AABXI
AAHBH
ABBLG
ABJNI
ABLBI
ABMVS
ABQRX
ABUCX
ACGFS
ACS
ADHLV
AEESW
AENEX
AFEFF
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CGR
CS3
CUPRZ
CUY
CVF
DU5
EBS
ECM
ED~
EIF
F5P
GGK
GNL
IH9
IHE
JG~
NPM
P2P
RNS
ROL
UI2
VF5
VG9
W1F
7X8
ID FETCH-LOGICAL-a339t-26c96476e688d229360523a3f9d3d591dc1e25b81239bf9c885afd41157870422
IEDL.DBID 7X8
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001604087000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1535-3907
IngestDate Wed Oct 29 17:07:19 EDT 2025
Sat Nov 08 03:22:45 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords AMR detection
diagnostic microbiology
mass spectrometry-based diagnostics
pathogen detection
clinical proteomics
taxonomic inference
proteotyping
bioinformatics workflows
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a339t-26c96476e688d229360523a3f9d3d591dc1e25b81239bf9c885afd41157870422
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0001-8304-2684
0000-0002-6213-7665
0000-0002-1595-1445
PMID 41159248
PQID 3266458543
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3266458543
pubmed_primary_41159248
PublicationCentury 2000
PublicationDate 2025-11-07
PublicationDateYYYYMMDD 2025-11-07
PublicationDate_xml – month: 11
  year: 2025
  text: 2025-11-07
  day: 07
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of proteome research
PublicationTitleAlternate J Proteome Res
PublicationYear 2025
SSID ssj0015703
Score 2.4776745
SecondaryResourceType review_article
Snippet Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 5336
SubjectTerms Bacteria - classification
Bacteria - isolation & purification
Computational Biology - methods
Humans
Proteomics - methods
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Tandem Mass Spectrometry - methods
Title From Identification to Insight: Making Full Use of the Diagnostic Potential of MS/MS Proteotyping in Clinical Microbiology Using Efficient Bioinformatics
URI https://www.ncbi.nlm.nih.gov/pubmed/41159248
https://www.proquest.com/docview/3266458543
Volume 24
WOSCitedRecordID wos001604087000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBZ5FJJL-sizjzCFXpXNSpYt5VLaJEsC9bKQB3tbbD1gS9dO4k2gPyX_NjOylz0FCr34YiRZ0jD-ZqT5Psa-lZrEA0zJdaIET4QN3BjneSg0hkOqVCbmdG9_ZcOhHo_NqEu4Nd21yoVPjI7a1ZZy5D2EGWmC2DaR3-_uOalG0elqJ6GxytYlQhmy6my8PEUgdqmWL1VxjO2zRQWP6PcK2xz9jlQI9cwfKRvFC19HmfFvM3j7v9_5jm11OBN-tIbxnq346gPbOF3Iu22z58FDPYO2Tjd0iTuY13BZNRSvn0AedaqAYlS4aTzUARAswll7Nw-7hRHOC1vjMPguv-rlVzCKc53_pSosmFbQ0Y7-gXy6ZHyCeE8BziN7BfYAP6d1R-BKpNE77GZwfn16wTudBl5IaeZcpJbqWVOfau0E4oeUcs2FDMZJp0zf2b4XqkQogUYRjNVaFcElRPOD3iIRYpetVXXl9xkE6wpvfCgxKkJok5hj5cpMZjL0MyutPGBfF6s-wfWiw42i8vVjM1mu-wHba7ductcSdkxoKIwz9cd_aP2JbQqS-KXMcfaZrQf0Av4Le2Of5tPm4TAaGD6Ho_wF847cpw
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=From+Identification+to+Insight%3A+Making+Full+Use+of+the+Diagnostic+Potential+of+MS%2FMS+Proteotyping+in+Clinical+Microbiology+Using+Efficient+Bioinformatics&rft.jtitle=Journal+of+proteome+research&rft.au=Muth%2C+Thilo&rft.au=Karlsson%2C+Roger&rft.au=Yu%2C+Yi-Kuo&rft.au=Alves%2C+Gelio&rft.date=2025-11-07&rft.eissn=1535-3907&rft.volume=24&rft.issue=11&rft.spage=5336&rft_id=info:doi/10.1021%2Facs.jproteome.5c00733&rft_id=info%3Apmid%2F41159248&rft_id=info%3Apmid%2F41159248&rft.externalDocID=41159248
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-3907&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-3907&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-3907&client=summon